Two health sector stocks, a cancer insurance provider and a drugstore operator, have qualified for my list of A-List Dividends picks, says J. Royden Ward, editor of Cabot Benjamin Graham Value Letter.
In addition to strong dividend records, to meet my criteria, a stock had to offer strong chances of outperforming the market during the next six to 12 months.
I also looked for high-quality companies with an S&P Quality Rating of A+, A or A-. Lastly, I looked for companies with excellent prospects for the year ahead.
Aflac (AFL) is the world's largest supplemental cancer insurance provider, deriving 75% of its business from Japan.
Most of Aflac's policies are individually underwritten and marketed at worksites through independent agents, with premiums paid by the employee. Aflac Japan provides insurance to one out of every four Japanese households.
Best Consumer Service Companies For 2015: Progress Energy Inc.(PGN)
Progress Energy, Inc., a utility holding company, engages in the generation, transmission, distribution, and sale of electricity in North Carolina, South Carolina, and Florida. It uses coal, oil, hydroelectric, natural gas, and nuclear power to generate electricity. The company also engages in various alternative energy projects to generate electricity from swine waste and other plant or animal sources, biomass, solar, hydrogen, and landfill-gas technologies. Progress Energy serves various industries, including chemicals, textiles, paper, food, metals, wood products, rubber and plastics, and stone products, as well as phosphate rock mining and processing, electronics design and manufacturing, and citrus and other food processing. It has approximately 22,000 megawatts of regulated electric generation capacity and serves approximately 3.1 million retail electric customers, as well as other load-serving entities. The company was formerly known as CP&L Energy, Inc. Progress En ergy, Inc. was founded in 1925 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Holly LaFon] ess Energy shares climbed over 2011 as the company announced in January it would merge with Duke Energy. Together, they will form the nation�� largest utility with a combined enterprise value of $65 billion and $37 billion in market cap. The new company will have 57 gigawatts of domestic generating capacity through a mix of coal, nuclear, natural gas, oil and renewable resources. Progress energy shareholders will receive an approximately 3 percent dividend increase.
Incidentally, development of a comprehensive energy policy was one of what Grantham called ��he most important and most dangerous issues��facing the world.
Progress is at the forefront of the push for nuclear energy in the U.S., which has been deemed the ��uclear renaissance.��Thirty-five percent of the electricity used by Progress Energy customers comes from one of their four nuclear sites, two in North Carolina, and one each in South Carolina and Florida. It plans to build another reactor in Levy County, Florida.
Revenue at Progress Energy has declined at a 2.6% annual rate over the past five years, and it achieved cash flow of $95 million in 2010, after three years of losses. Earnings have remained positive, reaching a record for the decade of $856 million in 2010.
RSC Holdings (RRR)
RSC is a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.
United Rentals (URI), one of RSC�� largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.
The company�� fleet utilization also
Top 10 Performing Companies To Watch For 2014: Endeavor IP Inc (ENIP)
Endeavor IP, Inc., formerly Finishing Touches Home Goods Inc., incorporated on December 8, 2009, is an integrated consulting firm that assists individuals, organizations, companies and government agencies in finding solutions to home and workplace-related barriers for seniors and people with disabilities, as well as ergonomics consultancy. The Company�� focused on providing services and products that helps to create barrier-free homes and workplace environments. The Company provides consulting services, including site audits and accessibility/ergonomic planning and development; installation and sales of accessibility, ergonomic and safety products, ergonomic consultancy for homes and businesses. During the fiscal year ended October 31, 2012, the Company focuses on providing services in two main areas: Accessibility and Ergonomics in the workplace and at home.
The Company offer functional assessment services for commercial and residential properties and offer recommendations based on its assessment to improve accessibility and safety of these sites. The Company offers its clients practical ergonomic solutions by offering consulting services, such as Ergonomic Assessments, Physical Demands Assessments, Disability Management / Return to Work, and Occupational Health and Safety. The Company�� consulting services include Workplace Risk Assessments, Office Layout, New Equipment Selection, Display Screen Equipment (DSE) Assessments, Accessibility and Disability Access Audits, Retail Ergonomics and Ergonomics Standards.
Advisors' Opinion:- [By James E. Brumley]
They say a company is judged by the company it keeps. What's less said - though never disputed - is that a company is equally judged by the kind of talent it can attract... winning people tend to only work for winning companies. In that light, the fact that the newest chief of Endeavor IP Inc. (OTCBB:ENIP) is a former executive from the ranks of Rambus Inc. (NASDAQ:RMBS) and Tessera Technologies, Inc. (NASDAQ:TSRA) should underscore just how seriously the market should be taking ENIP. RMBS and TSRA didn't become large powerhouses by hiring folks who don't know what they're doing, and conversely, the fact that a former Rambus and Tessera Technologies guy was willing to step into the unknown and take the helm at Endeavor IP speaks volumes about the potential of the young company's IP portfolio.
- [By Bryan Murphy]
The winds of change are blowing within the patent-enforcement world. If you don't believe it, just ask Google Inc. (NASDAQ:GOOG), Akamai Technologies, Inc. (NASDAQ:AKAM), and Soverain Software LLC. All three companies recently found themselves on the losing end of a court decision - the appeals court, to be specific - that likely could have come out very differently were we in the patent-enforcement environment from just a couple of years ago. Things are a bit tougher for patent owners now. That change, however, may be a very good thing for patent-protection company Endeavor IP Inc. (OTCBB:ENIP) and ENIP shareholders.
- [By John Udovich]
Although some view patent investors or speculators as nothing more than "patent trolls," small cap patent stocks RPX Corporation (NASDAQ: RPXC), Marathon Patent Group Inc (OTCBB: MARA) and Endeavor IP Inc (OTCBB: ENIP) are a couple of interesting options that allow retail investors to invest in patents as they either invest in patents themselves or they provide patent related services. However, there could be risks associated with investing in patent stocks because a bi-partisan bill called the Innovation Act (H.R. 3309) is�working its way through Congress to try and reign in the activities of so-called�patent trolls or companies�who go out and buy or license patents from others and then target alleged infringers with lawsuits.
Top 10 Performing Companies To Watch For 2014: Cerus Corporation(CERS)
Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The company?s INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. It markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. Cerus Corporation has collaboration agreements with Baxter International, Inc.; and BioOne Corporation, as well as the United States Armed Forces. The company was founded in 1991 and is based in Concord, California.
Advisors' Opinion:- [By Seth Jayson]
Cerus (Nasdaq: CERS ) is expected to report Q1 earnings on April 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cerus's revenues will expand 15.0% and EPS will remain in the red.
Top 10 Performing Companies To Watch For 2014: Nestle SA (NSRGY.PK)
Nestle SA is a company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. The Company has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. Nestle is also active in the pharmaceutical sector. It divides its products into nine categories: Prepared dishes and cooking aids, Beverages, Confectionery, Ice cream, Water, PetCare, Milk products, Nutrition and Pharma. It has numerous subsidiaries engaged in various areas of activity, including Alcon Ophthalmika GmbH (Austria), Alcon Bulgaria EOOD (Bulgaria) and Galderma Laboratorium GmbH (Germany) for pharmaceuticals; Novartis Nutrition GmbH (Austria) and Hjem-IS A/S (Denmark) for food and beverages, and Galderma International SAS (France) and Galderma Laboratorium GmbH (Germany) for health and beauty activities. The Company is headquartered in Vevey, Switzerland. In July 2008, Novartis AG acquired a 25% stake in Alcon, Inc. from Nestle SA. In March 2010, the Company acquired Kraft Foods Inc' frozen pizza business.
In April 2008, L'Oreal and Nestle SA's joint venture, Galderma Pharma S.A., announced that its United States holding company, Galderma Laboratories, Inc., had acquired approximately 97% interest in CollaGenex Pharmaceuticals, Inc. During the year ended December 31, 2004, Nestle had 500 factories in 83 countries around the world. In 2004, 15 factories were acquired or opened and 29 closed or divested.
Advisors' Opinion:- [By Tim McAleenan Jr.]
I do not mention these things to discourage you from international stocks. I have been purchasing BP (BP) between $39-$43, and I will eventually purchase Anheuser-Busch (BUD), Nestle (NSRGY.PK), Royal Dutch Shell (RDS.B), and two or three other international companies when the stars line up. My point is that you should not feel an obligation to own international stocks simply for diversification's sake. If you find a good international stock with a business model you understand and it trades at an attractive price, then great. You should buy it. But owning international stocks does not have to be a necessary part of your strategy. Despite what Mankiw advises in the New York Times, you can build a diversified collection of "global stocks" simply by investigating where certain American multinationals generate the bulk of their sales and earnings.
Top 10 Performing Companies To Watch For 2014: Tennant Company(TNC)
Tennant Company engages in the design, manufacture, and marketing cleaning solutions worldwide. The company offers floor maintenance and outdoor cleaning equipment; chemical-free cleaning technologies; and specialty surface coatings and related products for protecting, repairing, and upgrading floors. Its products are used to clean and coat surfaces in factories, office buildings, parking lots and streets, airports, hospitals, schools, warehouses, shopping centers, and other retail environments. The company also provides parts, consumables, and service maintenance and repair; business solutions, such as pay-for-use offerings, and rental and leasing programs; and cleaning technologies that enhance the performance of its cleaning equipment. In addition, it offers Green Machine 500ze, an electric vacuum street sweeper to clean crowded urban areas. The company serves building service contract cleaners, end-user businesses, healthcare facilities, and schools, as well as local, state, and federal governments through its direct sales and service organization, and authorized distributors. Tennant Company was founded in 1870 and is based in Minneapolis, Minnesota.
Advisors' Opinion:- [By Marc Bastow]
Floor maintenance and cleaning service company Tennant (TNC) raised its quarterly dividend 11% to 20 cents per share payable June 6 to shareholders of record May 30.
TNC Dividend Yield: 1.29%
Top 10 Performing Companies To Watch For 2014: Cynosure Inc.(CYNO)
Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. Its aesthetic treatment systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag, and diode lasers, as well as intense pulsed light. The company?s aesthetic treatment systems comprise the Elite product line for hair removal, treatment of facial, and leg veins and pigmentations; the Smartlipo product line for LaserBodySculpting for the removal of unwanted fat; the Cellulaze, SmoothShapes XV, and TriActive product line for the temporary and long-term reduction in the appearance of cellulite; the Affirm/SmartSkin product line for anti-aging applications, such as treatments for wrinkles, skin texture, skin discoloration, and skin tightening; the Cynergy product line for the treatment of vascular lesions; and the Accolade product line for the removal of benign pigmented lesion s, as well as multi-colored tattoos. It sells its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Korea, China, Japan, and Mexico; and through international distributors in 84 other countries. Cynosure, Inc. was founded in 1991 and is based in Westford, Massachusetts.
Advisors' Opinion:- [By John Udovich]
Large cap serial acquirer�Valeant Pharmaceuticals International Inc (NYSE: VRX) is teaming up with activist investor�Bill Ackman to pursue large cap Botox maker Allergan, Inc (NYSE: AGN), but stocks like Cutera, Inc (NASDAQ: CUTR), Cynosure, Inc (NASDAQ: CYNO), PhotoMedex Inc (NASDAQ: PHMD) and Syneron Medical Ltd (NASDAQ: ELOS)�actually offer investors more exposure to the growing anti aging and aesthetics market (Note: See my recent article: These Small Caps Seek to Treat Your Crow�� Feet and Double Chin (RVNC & KYTH)). To begin with, Valeant Pharmaceuticals International has a wide focus on neurology, dermatology and infectious diseases�but acquiring the maker of Botox won�� be its first foray into the aesthetic market�because earlier this year, the company completed its acquisition of Solta Medical Inc (NASDAQ: SLTM) -�a designer, developer, manufacturer and marketer of�energy-based medical device systems for aesthetic applications.�And while�Allergan, Inc may be most well known for Botox, its actually a pretty big�company focused on a diverse range of areas, including ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics���meaning the following stocks offer investors better exposure to the aesthetics market:
- [By Rich Duprey]
Aesthetic-laser maker Cynosure (NASDAQ: CYNO ) announced yesterday that it had completed the acquisition of rival laser specialist Palomar Medical Technologies for $146 million cash and 6 million shares for a total value of around $294 million.
- [By Seth Jayson]
There's no foolproof way to know the future for Cynosure (Nasdaq: CYNO ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
Top 10 Performing Companies To Watch For 2014: ICON plc(ICLR)
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, the United States, and rest of Europe. It specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. The company?s clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. Its clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynam ic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, contract staffing, and electronic endpoint adjudication. In addition, the company offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.
Advisors' Opinion:- [By Louis Navellier]
European Stocks to Buy: ICON Public Limited (ICLR)
ICON Public Limited Company (ICLR) is a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, the United States, and Europe. They provide management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies as well as lab services for companies conducting trials. The company has posted triple digit earnings gains and posted four consecutive positive earnings surprises in the past year. Analysts have been raising their estimates for the Irish company and Portfolio Grader raised the stock to an A last month. The stock is a strong buy at today�� price.
No comments:
Post a Comment